Karolinska Development AB (OSTO:KDEV) COGS-to-Revenue : 0.00 (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Karolinska Development AB COGS-to-Revenue?

Karolinska Development AB's Cost of Goods Sold for the three months ended in Mar. 2024 was kr0.00 Mil. Its Revenue for the three months ended in Mar. 2024 was kr0.47 Mil.

Karolinska Development AB's COGS to Revenue for the three months ended in Mar. 2024 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Karolinska Development AB's Gross Margin % for the three months ended in Mar. 2024 was N/A%.

Karolinska Development AB COGS-to-Revenue Historical Data

The historical data trend for Karolinska Development AB's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Karolinska Development AB COGS-to-Revenue Chart

Karolinska Development AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

Karolinska Development AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															-	-	-	-	-

Karolinska Development AB COGS-to-Revenue Calculation

Karolinska Development AB's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	2.014
	=	0.00

Karolinska Development AB's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0.471
	=	0.00

Karolinska Development AB (OSTO:KDEV) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Karolinska Development AB's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0.471
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Karolinska Development AB COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Karolinska Development AB's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Karolinska Development AB (OSTO:KDEV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Karolinska Development AB (OSTO:KDEV) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

2I9:Germany

Address

TomtebodavAgen 23 A, Solna, SWE, SE-171 65

Website

https://www.karolinskadevelopment.com

Karolinska Development AB is a life science investment company. It is focused on identifying breakthrough medical innovations in the Nordic region. It selects commercially attractive medical innovations, develops innovations to the stage where the return on investment can be achieved and commercializes the innovations through the sale of companies or out-licensing of products. The company focused on profiles namely Aprea Therapeutics; Modus Therapeutics; BioArctic; Umecrine Cognition; and OssDsign.

Karolinska Development AB (OSTO:KDEV) Headlines

No Headlines